cannabinoid receptor 1
| GO Term | Evidence Code | PMID |
|---|---|---|
| cytoplasm | ||
| mitochondrion | ||
| mitochondrial outer membrane | ||
| plasma membrane | ||
| plasma membrane |
| GO Term | Evidence Code | PMID |
|---|---|---|
| G protein-coupled receptor activity | ||
| cannabinoid receptor activity | ||
| cannabinoid receptor activity | ||
| protein binding | ||
| identical protein binding |
| Gene Ontology |
|---|
| cannabinoid receptor activity |
| cannabinoid signaling pathway |
| InterPro |
|---|
| Cannabinoid receptor family |
| Cannabinoid receptor type 1 |
| G protein-coupled receptor, rhodopsin-like |
| GPCR, rhodopsin-like, 7TM |
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:0080855 | Parkinsonism | |
| DOID:10763 | hypertension | |
| DOID:1875 | impotence | |
| DOID:2234 | focal epilepsy | |
| DOID:5419 | schizophrenia | |
| DOID:750 | peptic ulcer disease | |
| DOID:9743 | diabetic neuropathy | |
| DOID:9970 | obesity |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.4.0
Last updated: December 8, 2025